A comprehensive view of Mallinckrodt PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Mallinckrodt announces FDA approval of supplemental new drug application for Acthar Gel single-dose pre-filled SelfJect injector; launch expected in the US during the second half of 2024
Published:
March 05, 2024
by ENP Newswire
|
Ask us about our Health Care Sector market view